iQ3Corp Ltd Stocks

A$ 0Last Updated 23.03.2026

Issuer Rating

Performance

Modest

Risk

Low

Recommendation

Sell

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
A$ 0
Key Takeaways

Risk factor

Considerable default risk

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

iQ3Corp Ltd provides capital raising and corporate advisory services to listed and unlisted companies in the life science industry in Australia. The company operates in two segments, Consulting Services, and Shared Services. It offers advisory services on initial public offerings, listings, private equity, mergers and acquisitions, structured finance, strategic matters, restructuring and capital structure, and corporate finance. The company also provides sell-side, buy-side, and NSX nominated advisory services. It serves corporations, partnerships, institutions, governments, and individuals. The company was incorporated in 2012 and is based in Sydney, Australia.

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks